Work

Targeting IL-33/ST2 Signaling Alters Cardiac Structure and Function in Hypertensive Heart Disease

Year: 2024

Type: article

Source: JACC Basic to Translational Science

DOI: 10.1016/j.jacbts.2024.09.006

Authors: Jean W. Wassenaar, C. Duncan Smart, Daniel J. Fehrenbach, Vineet Agrawal, Matthew M. Dungan, Niki L. Fortune, Lin Zhong, Anna R. Hemnes, R. Stokes Peebles, Francis J. Miller, Amanda C. Doran, Meena S. Madhur

Institutions: Vanderbilt University Medical Center, Vanderbilt University, Indiana University Indianapolis

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,650

Funders: U.S. Department of Veterans Affairs, American Heart Association, Beckman Coulter Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: G1189402835, Interleukin-21 and endothelial dysfunction in hypertension, G2095241056, G3668951374, Medical Scientist Training Program, G4945577397, Defining Novel Inflammatory Pathways in Hypertension and Aortic Dissection, G7657926182, G8489868044, G9000039349, G9000051932, G9000056693, G9000186605, Immunology and Infectious Diseases Training Program, Immune Modulation in Hypertension, Clinical Pharmacology Training Program

OpenAlex ID: W4405519936

FWCI: 0.273

Cites: 5

Cited by: 2

Related to: 10